[go: up one dir, main page]

SV2006002123A - Profarmacos de esteroides con accion androgenica ref. p-sv-78.334/msu - Google Patents

Profarmacos de esteroides con accion androgenica ref. p-sv-78.334/msu

Info

Publication number
SV2006002123A
SV2006002123A SV2005002123A SV2005002123A SV2006002123A SV 2006002123 A SV2006002123 A SV 2006002123A SV 2005002123 A SV2005002123 A SV 2005002123A SV 2005002123 A SV2005002123 A SV 2005002123A SV 2006002123 A SV2006002123 A SV 2006002123A
Authority
SV
El Salvador
Prior art keywords
steroid
propharms
msu
androgenic action
androgenic
Prior art date
Application number
SV2005002123A
Other languages
English (en)
Inventor
Peter Droescher
Walter Elger
Alexander Hillisch
Gudrun Reddersen
Sven Ring
Birgitt Schneider
Ralf Wyrwa
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of SV2006002123A publication Critical patent/SV2006002123A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0044—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an estrane or gonane skeleton, including 18-substituted derivatives and derivatives where position 17-beta is substituted by a carbon atom not directly bonded to another carbon atom and not being part of an amide group

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

PROFARMACOS DE ESTEROIDES CON ACCION ANDROGENICA DE LA FORMULA GENERAL (I), EN LOS CUALES EL GRUPO Z ESTA UNIDO CON EL ESTEROIDE, (VER FORMULA), COMPOSICIONES FARMACEUTICAS, QUE CONTIENEN ESTOS COMPUESTOS, ASI COMO SU USO PARA LA PREPARACION DE MEDICAMENTOS CON ACCION ANDROGENICA
SV2005002123A 2004-05-21 2005-05-23 Profarmacos de esteroides con accion androgenica ref. p-sv-78.334/msu SV2006002123A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004025986A DE102004025986A1 (de) 2004-05-21 2004-05-21 Steroid-Prodrugs mit androgener Wirkung

Publications (1)

Publication Number Publication Date
SV2006002123A true SV2006002123A (es) 2006-02-15

Family

ID=34968657

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2005002123A SV2006002123A (es) 2004-05-21 2005-05-23 Profarmacos de esteroides con accion androgenica ref. p-sv-78.334/msu

Country Status (22)

Country Link
EP (1) EP1747229A1 (es)
JP (1) JP2007538026A (es)
CN (1) CN1993375A (es)
AR (1) AR049547A1 (es)
AU (1) AU2005245568A1 (es)
BR (1) BRPI0510136A (es)
CA (1) CA2564963A1 (es)
CR (1) CR8785A (es)
DE (1) DE102004025986A1 (es)
EA (1) EA200602049A1 (es)
EC (1) ECSP067028A (es)
GT (1) GT200500122A (es)
IL (1) IL179293A0 (es)
MX (1) MXPA06013469A (es)
NO (1) NO20065885L (es)
PA (1) PA8633601A1 (es)
PE (1) PE20060271A1 (es)
SV (1) SV2006002123A (es)
TW (1) TW200613317A (es)
UY (1) UY28911A1 (es)
WO (1) WO2005113575A1 (es)
ZA (1) ZA200610769B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10027887A1 (de) 2000-05-31 2001-12-13 Jenapharm Gmbh Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
US7534780B2 (en) 2004-05-21 2009-05-19 Bayer Schering Pharma Aktiengesellschaft Estradiol prodrugs
DE102005057224A1 (de) * 2005-11-29 2007-05-31 Bayer Schering Pharma Ag Prodrugs ERß-selektiver Substanzen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE102005057408A1 (de) * 2005-11-30 2007-05-31 Bayer Schering Pharma Ag Sulfamoylsulfonat-Prodrugs
CN101708338B (zh) * 2008-12-26 2014-06-04 中国人民解放军军事医学科学院放射与辐射医学研究所 含甾体结构的前药及其高度分散制剂
CN102964417A (zh) * 2012-11-30 2013-03-13 华中药业股份有限公司 17-羟基四氢吡喃醚甾族化合物的合成方法
CN107556258B (zh) * 2017-08-22 2021-06-04 湖北江田精密化学有限公司 一种4-氨基-2-氯-5(1h-四唑基-5)苯磺酰胺的制备方法
EP3533619A1 (en) * 2018-03-02 2019-09-04 Basf Se Heat sensitive recording material and color developer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH545316A (de) * 1970-07-17 1973-12-15 Hoffmann La Roche Verfahren zur Herstellung von Acylderivaten
US5001234A (en) * 1987-04-16 1991-03-19 The Upjohn Company Cyclic hydrocarbons with an aminoalkyl sidechain
US5571933A (en) * 1994-11-17 1996-11-05 Duquesne University Of The Holy Ghost Derivatives of estra 1,3,5(10)triene-17-one, 3-amino compounds and their use
DE19712488A1 (de) * 1997-03-25 1998-10-01 Knoell Hans Forschung Ev Steroidsulfamate, Verfahren zu ihrer Herstellung und Anwendung derselben
DE10027887A1 (de) * 2000-05-31 2001-12-13 Jenapharm Gmbh Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen

Also Published As

Publication number Publication date
PA8633601A1 (es) 2006-07-03
PE20060271A1 (es) 2006-05-25
NO20065885L (no) 2006-12-19
MXPA06013469A (es) 2007-01-23
ECSP067028A (es) 2006-12-29
EP1747229A1 (de) 2007-01-31
IL179293A0 (en) 2007-03-08
ZA200610769B (en) 2008-08-27
CA2564963A1 (en) 2005-12-01
WO2005113575A1 (de) 2005-12-01
JP2007538026A (ja) 2007-12-27
DE102004025986A1 (de) 2005-12-15
GT200500122A (es) 2006-01-24
TW200613317A (en) 2006-05-01
CN1993375A (zh) 2007-07-04
AR049547A1 (es) 2006-08-16
BRPI0510136A (pt) 2007-10-02
UY28911A1 (es) 2005-12-30
AU2005245568A1 (en) 2005-12-01
CR8785A (es) 2007-02-05
EA200602049A1 (ru) 2007-06-29

Similar Documents

Publication Publication Date Title
ECSP077316A (es) Compuestos imidazo-3-il-amina bicíclicos sustituidos
CL2003002731A1 (es) Compuesto derivado de quinazolina de formula definida, que actua como inhibidor de la kinasa aurora; procedimiento de preparacion del compuesto; composicion farmaceutica que comprende al compuesto y uso del compuesto; util para el tratamiento de enfe
UY28342A1 (es) Nuevos compuestos
UY29530A1 (es) Compuestos quimicos
AR027060A1 (es) Bases de mannich de 1-naftol y 2-naftol sustituidos, procedimiento para su preparacion, medicamentos que contienen estos compuestos, asi como el uso deestos compuestos para la fabricacion de medicamentos
ECSP077302A (es) 6H-[1]BENZOPIRANO[4,3-b]QUlNOLINAS, Y SU USO COMO AGENTES ESTROGENICOS
CL2007003202A1 (es) Compuestos derivados de espiroindolinona; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de trastornos de proliferacion celular.
CL2007003244A1 (es) Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
CL2008001951A1 (es) Compuestos derivados de imidazo[1,2-a]pirimidin-2-ilmetil sustituidos; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el trastorno del sueno, depresion, ansiedad, trastorno relacionado con el abuso de sustancias, entre otras.
GT201000047A (es) Mejoras en compuestos organicos o relacionadas con los mismos
CL2009000281A1 (es) Compuestos derivados de 5,6-dihidro-pirrolo-[2,1-a]-isoquinolinas y pirrolo-[2,1-a]-isoquinolinas; composicion farmaceutica que comprende a dichos compuestos; y uso para el tratamaiento de trastornos de la fertilidad.
CL2007002856A1 (es) Compuestos derivados de pirazolo(1,5)pirimidina; composicion farmaceutica qu lo comprende;y su uso para tratar el cancer.
UY27894A1 (es) Derivados de cinamida.
CU20110185A7 (es) Nuevos derivados de compuestos de [3,2-c]pirazol esteroidal con actividad glucocorticoide
AR055319A1 (es) Derivados de isoquinoleina, composiciones farmaceuticas y usos
SV2006002123A (es) Profarmacos de esteroides con accion androgenica ref. p-sv-78.334/msu
AR072425A1 (es) Uso de nifurtimox para el tratamiento de giardiasis
AR058127A1 (es) Derivados de piperidina antagonistas de cgrp, procedimientos para su preparacion asi como su uso como medicamentos
SV2006002121A (es) Prodrogas de estradiol ref. p-sv-78.325/msu
GT200500340A (es) Derivados de octahidropirrolo [3,4-c] pirrol
SV2006002122A (es) Prodrogas de estriol y estetrol ref. p-sv-78.343/msu
ECSP077366A (es) Fenoles de carbonilo fenantridina como moduladores de citoquina
PA8629401A1 (es) D-homo-17-cloro-16 (17) eno esteroides
ECSP11011501A (es) 17 -alquil-17 -oxi-estratrienos
UY28846A1 (es) D-homo-17-cloro-16 (17) eno esteroides

Legal Events

Date Code Title Description
FD Lapse